Cargando…
The effectiveness of cinacalcet: a randomized, open label study in chronic hemodialysis patients with severe secondary hyperparathyroidism
Background: Secondary hyperparathyroidism (SHPT) is associated with high incidences of cardiovascular disease, bone fracture, and mortality. This study was conducted to demonstrate the effectiveness of cinacalcet treatment on chronic kidney disease-mineral bone disorder (CKD-MBD) markers in chronic...
Autores principales: | Susantitaphong, Paweena, Vadcharavivad, Somratai, Susomboon, Teerada, Singhan, Wanchana, Dumrongpisutikul, Netsiri, Jakchairoongruang, Ketsuda, Eiam-Ong, Somchai, Praditpornsilpa, Kearkiat |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6493313/ https://www.ncbi.nlm.nih.gov/pubmed/31014177 http://dx.doi.org/10.1080/0886022X.2018.1562356 |
Ejemplares similares
-
The impact of CASR A990G polymorphism in response to cinacalcet treatment in hemodialysis patients with secondary hyperparathyroidism
por: Ngamkam, Jaruwan, et al.
Publicado: (2021) -
Comparison of Tacrolimus Intra-Patient Variability during 6–12 Months after Kidney Transplantation between CYP3A5 Expressers and Nonexpressers
por: Nuchjumroon, Almas, et al.
Publicado: (2022) -
Vitamin D supplement on prevention of fall and fracture: A Meta-analysis of Randomized Controlled Trials
por: Thanapluetiwong, Saran, et al.
Publicado: (2020) -
Non‐Vitamin K Antagonist Oral Anticoagulants Provide Less Adverse Renal Outcomes Than Warfarin In Non‐Valvular Atrial Fibrillation: A Systematic Review and MetaAnalysis
por: Sitticharoenchai, Patita, et al.
Publicado: (2021) -
The world prevalence, associated risk factors and mortality of hepatitis C virus infection in hemodialysis patients: a meta-analysis
por: Greeviroj, Primploy, et al.
Publicado: (2022)